Rutherford 2 mean change in ldl c levels with evolocumab or placebo biweekly or monthly in hefh
Download
1 / 1

Change from baseline in LDL cholesterol (%) - PowerPoint PPT Presentation


  • 61 Views
  • Uploaded on

RUTHERFORD-2: mean change in LDL-c levels with evolocumab or placebo biweekly or monthly in HeFH. Change from baseline in LDL cholesterol (%). Raal et al., The Lancet Oct 2014.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Change from baseline in LDL cholesterol (%)' - dionysus-dale


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Rutherford 2 mean change in ldl c levels with evolocumab or placebo biweekly or monthly in hefh
RUTHERFORD-2: mean change in LDL-c levels with evolocumab or placebo biweekly or monthly in HeFH

Change from baseline in LDL cholesterol (%)

Raal et al., The Lancet Oct 2014


ad